Riegg, F.; Lutz, M.S.; Schmied, B.J.; Heitmann, J.S.; Queudeville, M.; Lang, P.; Jung, G.; Salih, H.R.; Märklin, M.
An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia. Cancers 2021, 13, 1632.
https://doi.org/10.3390/cancers13071632
AMA Style
Riegg F, Lutz MS, Schmied BJ, Heitmann JS, Queudeville M, Lang P, Jung G, Salih HR, Märklin M.
An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia. Cancers. 2021; 13(7):1632.
https://doi.org/10.3390/cancers13071632
Chicago/Turabian Style
Riegg, Fabian, Martina S. Lutz, Bastian J. Schmied, Jonas S. Heitmann, Manon Queudeville, Peter Lang, Gundram Jung, Helmut R. Salih, and Melanie Märklin.
2021. "An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia" Cancers 13, no. 7: 1632.
https://doi.org/10.3390/cancers13071632
APA Style
Riegg, F., Lutz, M. S., Schmied, B. J., Heitmann, J. S., Queudeville, M., Lang, P., Jung, G., Salih, H. R., & Märklin, M.
(2021). An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia. Cancers, 13(7), 1632.
https://doi.org/10.3390/cancers13071632